Abstract:Abstract Objectives MicroRNA-302a (miR-302a) has been implicated in the oncogenic processes, but its role in hepatocellular carcinoma (HCC) chemoresistance and related mechanisms are still unclear. Therefore, the aim of this study was to investigate the role of miR-302a in HCC chemoresistance and elucidate its underlying mechanism. Methods In this study, we detected the level of miR-302a in HCC tissues (including chemoresistant and chemosensitive tissues), non-tumor tissues, liver cancer cell lines, and 5-fluorouracil (5-FU)-resistant cells (HepG2/R). Additionally, we conducted cell viability, apoptosis, and autophagy analyses as well as assessed the levels of cleaved caspase-3, cleaved caspase-9, microtubule-associated protein 1 light chain 3 beta II (LC3B-II), Akt, and UNC-51 like kinase 1 (ULK1) in HepG2 cells transfected with miR-302a mimic or inhibitor prior to 5-FU treatment. Lastly, we predicted the target of miR-302a and verified the relationship between miR-302a and Akt by luciferase reporter and functional repair assays. Results Our results revealed that miR-302a was down-regulated in HCC tissues (p<0.01), especially in chemoresistant tissues (p<0.01). Consistently, the miR-302a level exhibited a lower expression in HepG2/R cells compared to their parental cells (p<0.01). Furthermore, the 5-FU-induced apoptosis and autophagy of HepG2 cells were promoted by miR-302a over-expression and diminished by miR-302a inhibition (p<0.01). Target analysis revealed that miR-302a could directly target Akt. Moreover, miR-302a inhibited Akt expression and subsequently elevated ULK1 expression (p<0.01). Inhibition of ULK1 could abrogate the sensitization of overexpressed miR-302a to 5-FU in HepG2 cells (p<0.01). Conclusions Altogether, our results demonstrate that the down-regulation of miR-302a promotes 5-FU resistance in HCC by attenuating the Akt/ULK1 axis-dependent autophagy and apoptosis.

What problem does this paper attempt to address?

The paper primarily explores the role of microRNA-302a (miR-302a) in chemotherapy resistance in hepatocellular carcinoma (HCC) and its related mechanisms. The main objectives and findings of the study can be summarized as follows: 1. **Background and Purpose**: - Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and chemotherapy is one of its main treatment methods. - Chemotherapy resistance is a significant factor affecting treatment efficacy, and the role of miR-302a in HCC chemotherapy resistance is not yet fully understood. - The study aims to investigate the role of miR-302a in HCC chemotherapy resistance and its potential mechanisms. 2. **Methods**: - Detect the expression levels of miR-302a in HCC tissues, non-tumor tissues, liver cancer cell lines, and 5-fluorouracil (5-FU) resistant cells. - Assess the effects on cell viability, apoptosis, and autophagy by transfecting miR-302a mimics or inhibitors, and detect the expression levels of related proteins. - Use bioinformatics tools to predict the target genes of miR-302a and verify the relationship between miR-302a and Akt. 3. **Results**: - miR-302a is significantly downregulated in HCC tissues, especially in chemotherapy-resistant tissues. - Overexpression of miR-302a promotes 5-FU-induced apoptosis and autophagy in HepG2 cells; conversely, inhibition of miR-302a weakens these effects. - miR-302a can directly target Akt, inhibiting Akt expression, thereby upregulating ULK1 expression. - Inhibition of ULK1 can reverse the enhanced sensitivity to 5-FU caused by miR-302a overexpression. - Overall, miR-302a affects 5-FU sensitivity by regulating Akt/ULK1 axis-dependent autophagy and apoptosis. 4. **Conclusion**: - Downregulated miR-302a promotes HCC cell resistance to 5-FU by weakening Akt/ULK1 axis-dependent autophagy and apoptosis. - These findings suggest that the miR-302a/Akt/ULK1 axis may be a potential strategy for treating HCC chemotherapy resistance. In summary, this study reveals the important role of miR-302a in regulating HCC chemotherapy resistance and proposes a possible molecular mechanism, where miR-302a regulates autophagy and apoptosis processes by affecting the Akt/ULK1 axis, thereby influencing 5-FU sensitivity. These findings provide new insights into understanding HCC chemotherapy resistance and may provide a theoretical basis for developing new therapies targeting chemotherapy resistance.

MicroRNA-302a enhances 5-fluorouracil sensitivity in HepG2 cells by increasing AKT/ULK1-dependent autophagy-mediated apoptosis